(Q34585183)

3 August 2017

1 reference

title

Novel pharmacotherapeutic approaches to prevention and treatment of GVHD. (English)

1 reference

3 August 2017

David A Jacobsohn

1

1 reference

3 August 2017

Georgia B Vogelsang

series ordinal

2

1 reference

3 August 2017

publication date

1 January 2002

1 reference

3 August 2017

1 reference

3 August 2017

volume

62

1 reference

3 August 2017

issue

6

1 reference

3 August 2017

page(s)

879-889

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-200262060-00002

3 August 2017

exact match

0 references

cites work

Tumor necrosis factor combines with IL-4 or IFN-gamma to selectively enhance endothelial cell adhesiveness for T cells. The contribution of vascular cell adhesion molecule-1-dependent and -independent binding mechanisms

1 reference

12 December 2020

Role of tumor necrosis factor-alpha inhibition with inflixiMAB in cancer therapy and hematopoietic stem cell transplantation

1 reference

12 December 2020

Identification of a binding site on Hsc70 for the immunosuppressant 15-deoxyspergualin

1 reference

12 December 2020

Transplantation of anergic histoincompatible bone marrow allografts

1 reference

12 December 2020

Hydroxychloroquine for the treatment of chronic graft-versus-host disease

1 reference

12 December 2020

The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease: rationale for the use of cytokine shields in allogeneic bone marrow transplantation

1 reference

12 December 2020

A survey of the prophylaxis and treatment of acute GVHD in Europe: a report of the European Group for Blood and Marrow, Transplantation (EBMT). Chronic Leukaemia Working Party of the EBMT

1 reference

12 December 2020

Treatment of acute graft-versus-host disease with methylprednisolone and cyclosporine with or without an anti-interleukin-2 receptor monoclonal antibody. A multicenter phase III study.

1 reference

12 December 2020

Thalidomide for the treatment of chronic graft-versus-host disease

1 reference

12 December 2020

Alternating-day cyclosporine and prednisone for treatment of high-risk chronic graft-v-host disease

1 reference

12 December 2020

T cell depletion with CAMPATH-1 in allogeneic bone marrow transplantation

1 reference

12 December 2020

Durable engraftment of major histocompatibility complex-incompatible cells after nonmyeloablative conditioning with fludarabine, low-dose total body irradiation, and posttransplantation cyclophosphamide

1 reference

12 December 2020

Anti-Tac-H, a humanized antibody to the interleukin 2 receptor with new features for immunotherapy in malignant and immune disorders.

1 reference

12 December 2020

Cyclosporine or cyclosporine plus methylprednisolone for prophylaxis of graft-versus-host disease: a prospective, randomized trial

1 reference

12 December 2020

Acute and chronic graft-versus-host disease after allogeneic peripheral-blood stem-cell and bone marrow transplantation: a meta-analysis

1 reference

12 December 2020

Improving the outcome of bone marrow transplantation by using CD52 monoclonal antibodies to prevent graft-versus-host disease and graft rejection

1 reference

12 December 2020

Intrathymic clonal deletion of V beta 6+ T cells in cyclophosphamide-induced tolerance to H-2-compatible, Mls-disparate antigens

1 reference

12 December 2020

Daclizumab, a humanized anti-interleukin-2 receptor alpha chain antibody, for treatment of acute graft-versus-host disease

1 reference

12 December 2020

Phototherapy in the treatment of cutaneous graft-versus-host disease. Our preliminary experience in resistant patients.

1 reference

12 December 2020

Rapamune (Sirolimus, rapamycin): an overview and mechanism of action.

1 reference

12 December 2020

Pathophysiologic mechanisms of acute graft-vs.-host disease

1 reference

12 December 2020

Treatment of chronic graft-versus-host disease with clofazimine

1 reference

12 December 2020

Interleukin 1 increases the binding of human B and T lymphocytes to endothelial cell monolayers

1 reference

12 December 2020

A humanized antibody that binds to the interleukin 2 receptor

1 reference

12 December 2020

Phase III study comparing methotrexate and tacrolimus (prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow transplantation

1 reference

12 December 2020

High-dose methylprednisolone treatment for acute graft-versus-host disease after bone marrow transplantation in adults

1 reference

12 December 2020

Molecular recognition of antigen involves lattice formation between CD4, MHC class II and TCR molecules

1 reference

12 December 2020

Drug therapy for acute graft-versus-host disease prophylaxis

1 reference

12 December 2020

Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates

1 reference

12 December 2020

Development of a simplified counterflow centrifugation elutriation procedure for depletion of lymphocytes from human bone marrow

1 reference

12 December 2020

Thalidomide as salvage therapy for chronic graft-versus-host disease

1 reference

12 December 2020

A clinical phase I/II study of recombinant human interleukin-1 receptor in glucocorticoid-resistant graft-versus-host disease

1 reference

12 December 2020

Monoclonal antibodies for the prevention of graft-versus-host disease and marrow graft rejection. The depletion of T cell subsets in vitro and in vivo.

1 reference

12 December 2020

High dose bolus methylprednisolone for the treatment of acute graft versus host disease

1 reference

12 December 2020

Effects of interferon-gamma and tumor necrosis factor-alpha on the expression of an Ia antigen on a murine macrophage cell line

1 reference

12 December 2020

Interaction of antigenic peptides with MHC and TCR molecules

1 reference

12 December 2020

Effect of total body irradiation, busulfan-cyclophosphamide, or cyclophosphamide conditioning on inflammatory cytokine release and development of acute and chronic graft-versus-host disease in H-2-incompatible transplanted SCID mice

1 reference

12 December 2020

Salvage therapy for refractory chronic graft-versus-host disease with mycophenolate mofetil and tacrolimus

1 reference

12 December 2020

1994 Consensus Conference on Acute GVHD Grading

1 reference

12 December 2020

A phase II study of BTI-322, a monoclonal anti-CD2 antibody, for treatment of steroid-resistant acute graft-versus-host disease.

1 reference

12 December 2020

Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors

1 reference

12 December 2020

Mycophenolate mofetil

1 reference

12 December 2020

Increased risk of infection in marrow transplant patients receiving methylprednisolone for graft-versus-host disease prevention

1 reference

12 December 2020

Methotrexate and cyclosporine versus cyclosporine alone for prophylaxis of graft-versus-host disease in patients given HLA-identical marrow grafts for leukemia: long-term follow-up of a controlled trial

1 reference

12 December 2020

Blocking both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance

1 reference

12 December 2020

Pathophysiology and treatment of graft-versus-host disease

1 reference

12 December 2020

Prednisone and azathioprine compared with prednisone and placebo for treatment of chronic graft-v-host disease: prognostic influence of prolonged thrombocytopenia after allogeneic marrow transplantation.

1 reference

12 December 2020

Antibodies to IFN-gamma prevent immunologically mediated intestinal damage in murine graft-versus-host reaction

1 reference

12 December 2020

Early treatment of acute graft-versus-host disease with high- or low-dose 6-methylprednisolone: a multicenter randomized trial from the Italian Group for Bone Marrow Transplantation

1 reference

12 December 2020

A randomized trial comparing prednisone with antithymocyte globulin/prednisone as an initial systemic therapy for moderately severe acute graft-versus-host disease

1 reference

12 December 2020

In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantation

1 reference

12 December 2020

Predictors of death from chronic graft-versus-host disease after bone marrow transplantation

1 reference

12 December 2020

Effects of tumor necrosis factor on the interferon-gamma-induced major histocompatibility complex class II antigen expression by human endothelial cells

1 reference

12 December 2020

Evaluation of a CD5-specific immunotoxin for treatment of acute graft-versus-host disease after allogeneic marrow transplantation

1 reference

12 December 2020

Treatment of chronic graft-versus-host disease with ultraviolet irradiation and psoralen (PUVA)

1 reference

12 December 2020

Etretinate therapy for refractory sclerodermatous chronic graft-versus-host disease

1 reference

12 December 2020

Demonstration of direct involvement of cytokines in graft-versus-host reactions using an in vitro human skin explant model

1 reference

12 December 2020

Management of acute graft-versus-host disease

1 reference

12 December 2020

Bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: importance of a graft-versus-leukaemia effect.

1 reference

12 December 2020

Graft-versus-host disease prevention in allogeneic bone marrow transplantation from histocompatible siblings. A pilot study using immunotoxins for T cell depletion of donor bone marrow

1 reference

12 December 2020

Macrophage priming and lipopolysaccharide-triggered release of tumor necrosis factor alpha during graft-versus-host disease

1 reference

12 December 2020

CTLA-4 is a second receptor for the B cell activation antigen B7

1 reference

12 December 2020

Mycophenolate mofetil in cadaveric renal transplantation. US Renal Transplant Mycophenolate Mofetil Study Group

1 reference

12 December 2020

Successful use of extracorporeal photochemotherapy in the treatment of severe acute and chronic graft-versus-host disease

1 reference

12 December 2020

Prednisone therapy for acute graft-versus-host disease: short- versus long-term treatment. A prospective randomized trial

1 reference

12 December 2020

Dose-reduced conditioning for allogeneic blood stem cell transplantation: durable engraftment without antithymocyte globulin

1 reference

12 December 2020

Cyclosporin A, FK-506, and rapamycin: pharmacologic probes of lymphocyte signal transduction

1 reference

12 December 2020

Treatment of graft-versus-host disease in human allogeneic marrow graft recipients: a randomized trial comparing antithymocyte globulin and corticosteroids

1 reference

12 December 2020

Cyclosporine, methotrexate, and prednisone compared with cyclosporine and prednisone for prophylaxis of acute graft-versus-host disease

1 reference

12 December 2020

Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor, and immune interferon

1 reference

12 December 2020

10.2165/00003495-200262060-00002

Identifiers

DOI

1 reference

Dimensions Publication ID

3 August 2017

1039665719

0 references

1 reference